GlassScriptPhysician profile
Ingrid K Roskos
NPI 1235113770
$4,734.82
in general payments reported to CMS, 2019-2025
39 companies · $525 in 2025
The $525 reported for 2025 was more than what 81% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $597 · 2020: $405 · 2021: $667 · 2022: $1,000 · 2023: $957 · 2024: $584 · 2025: $525.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,066.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,065.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $769.00 | 2019-2024 | Lo Loestrin Fe, Liletta, Orilissa |
| Evofem Biosciences, INC. | $497.43 | 2021-2025 | Phexxi, Solosec, Phexx |
| Astellas Pharma US INC | $418.18 | 2019-2025 | Veozah, Myrbetriq |
| Mayne Pharma Commercial LLC | $350.68 | 2021-2024 | |
| Sumitomo Pharma America, INC. | $281.68 | 2023-2025 | Myfembree |
| Therapeuticsmd, INC. | $226.84 | 2019-2022 | |
| Mylan Pharmaceuticals INC. | $211.28 | 2019-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $173.34 | 2019-2025 | |
| Hologic Sales and Service, LLC | $161.92 | 2019-2023 | Aptima |
| Avion Pharmaceuticals | $149.73 | 2021-2024 | Balcoltra, NP Thyroid 60 |
| Myovant Sciences INC. | $149.46 | 2021-2022 | |
| Organon LLC | $142.51 | 2021-2025 | Nexplanon |
| Pfizer INC. | $134.16 | 2021-2025 | |
| Avanos Medical | $132.07 | 2020 | |
| Daiichi Sankyo INC. | $116.38 | 2019-2024 | Injectafer |
Show all 39 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Scynexis, INC. | $111.14 | 2021-2022 | |
| Millicent US INC | $104.81 | 2024-2025 | Intrarosa, Femring, Femlyv |
| Exact Sciences Corporation | $61.59 | 2024-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Merck Sharp & Dohme LLC | $52.21 | 2020-2023 | Gardasil 9 |
| Asensus Surgical, INC. | $47.09 | 2019-2023 | Senhance |
| Pacira Pharmaceuticals Incorporated | $41.00 | 2020-2025 | Exparel |
| Coopersurgical, INC. | $39.35 | 2021-2022 | |
| Alfasigma USA, INC. | $38.60 | 2022 | |
| Lupin INC. | $36.59 | 2019-2020 | |
| Innovation Technologies INC | $28.63 | 2025 | Irrisept |
| Heron Therapeutics, INC. | $27.74 | 2023 | Zynrelef |
| Vertical Pharmaceuticals, LLC | $27.28 | 2019 | |
| Novo Nordisk INC | $26.84 | 2020-2024 | Wegovy |
| Ethicon US, LLC | $22.11 | 2025 | Ethicon |
| Acella Pharmaceuticals, LLC | $20.59 | 2024 | NP Thyroid 60 |
| Roche Diagnostics Corporation | $17.70 | 2019 | |
| Agile Therapeutics, INC. | $17.67 | 2022 | |
| Becton, Dickinson and Company | $17.66 | 2022 | |
| Vertex Pharmaceuticals Incorporated | $17.12 | 2025 | |
| Azurity Pharmaceuticals, INC. | $17.08 | 2023 | Adthyza |
| Shield Therapeutics INC | $13.18 | 2023 | Accrufer |
| Abbott Laboratories | $12.23 | 2022 | |
| Renovia INC | $11.05 | 2021 | |
| Amag Pharmaceuticals, INC. | $10.90 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ingrid Roskos listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.